Skip to main content
SpringerLink
Log in

The contribution of nuclear medicine to the patient with infection

  • Review Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Nuclear medicine imaging of infection has two major indications: (a) the localization of a focus of infection in patients with fever of unknown origin; in this context the radio-pharmaceutical should be highly sensitive whereas specificity is not so important because subsequent biopsy or morphologically based imaging can be performed; (b) the diagnosis of an infection in patients with localized symptoms, for example after surgery, when normal anatomy is absent or when metal implants prevent computed tomography or magnetic resonance imaging. In these latter cases high sensitivity and to an even greater extent high specificity are mandatory to guide further clinical management (conservative or surgical). All radiopharmaceuticals available to date, such as technetium-99m nanocolloids, gallium-67 citrate, indium-111- and99mTc-labelled white blood cells,99mTc-antigranulocyte antibodies, and99mTc-or111In-la-belled unspecific human immunoglobulin, have different biodistributions and different physical characteristics. The absence of physiological uptake in an organ and the radiation exposure of a patient are reasons to use different radiopharmaceuticals in different clinical situations, adapted to the inidividual carcumstances of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Woods G, Gutierrez Y, Walker D, Purtilo D, Shanley J. Diagnostic pathology of infectious diseases. Philadelphia: Lea & Febiger, 1993.

    Google Scholar 

  2. Goldenberg DM, Sharkey RM, Udem S, Vagg R, Levine GM, Conte P, Swayne LC, Hansen HJ, Cunniff D, Anton J, Linke MJ, Smulian G, Walzer PD. Immunoscintigraphy of Pneumocystis carinii pneumonia in AIDS patients.J Nucl Med 1994; 35;1028–1034.

    Google Scholar 

  3. Bomanji J, Solanki KK, Britton KE, Siraj Q, Small M. Imaging infection with Tc-99m-radiolabelled “infecton”. Eur J Nucl Med 1993; 20: 834.

    Google Scholar 

  4. Myron I, Cybulsky M, Chan KW, Movat HZ. Neutrophil emigration. Quantification, kinetics, and role of mediators. In: Poste G, Crooke ST, eds.Cellular and molecular aspects inflammation. New York: Plenum, 1988.

    Google Scholar 

  5. Becker W, Goldenberg DM, Wolf F. The use ofmonoclonal antibodies and antibody fragments in the imaging of infectious lesions.Semin Nucl Med 1994; XXIV: 142–153.

    Google Scholar 

  6. Radiation dose to the patients from radiopharmaceuticals. Gallium citrate (ICRP publication no. 53).Ann ICRP 1987; 18:141–143.

    Google Scholar 

  7. Saptogino A, Becker W, Wolf F. Biokinetics and estimation of dose from Tc-99m-labelled polyclonal human immunoglobulin (HIG).Nucl Med 1991; 30: 18–23.

    Google Scholar 

  8. Buiijs WCAM, Oyen WIG, Claessens RAMJ, Koenders EB, Meeuwis APW, Corsens FHM. Biodistribution and radiation dosimetry of indium-111 labelled immunoglobulin G.Eur J Nucl Med 1990; 16: 433.

    Google Scholar 

  9. Radiation dose to patients from radiopharmaceuticals. Technetium labelled white blood cell (leucocytes) (ICRP publication no. 53).Ann ICRP 1987; 18: 231–232.

    Google Scholar 

  10. Radiation dose to the patients from radiopharmaceuticals. Indium labelled white blood cells (leukocytes) (ICRP publication no. 53).Ann ICRP 1987; 18: 255–256.

    Google Scholar 

  11. Joseph K, Höffken H, Bosslet K, Schorlemmer HU. In-vivo labelling of granulocytes with Tc-99m anti-NCA monoclonal antibodies from imaging inflammation.Eur J Nucl Med 1988; 14:367–373.

    Google Scholar 

  12. Hoffer P. Gallium: Mechanisms.J Nucl Med 1980; 21: 282–285.

    Google Scholar 

  13. Petersdorf RG, Beeson PB. Fever of unknown origin: report of 100 cases.Medicine 1961; 40: 1–30.

    Google Scholar 

  14. Shoen RP, van Ommen RA. Fever of obscure origin.Am J Med 1963: 34: 486.

    Google Scholar 

  15. Frayha R, Uwaydah M. Fever of unknown origin.Lab Med J 1973;26:49.

    Google Scholar 

  16. Howard P Jr, Hahn HH, Palmer PL. Fever of unknown origin. A prospective study of 100 patients.Tex Med 1977; 73: 56.

    Google Scholar 

  17. Larson EB, Featherstone HJ, Petersdorf RG. Fever of undermined origin: diagnosis and follow-up in 105 patients — 1970–1980.Medicine 1982; 61: 269.

    Google Scholar 

  18. Knockaert DC, Vanneste LJ, Vanneste SB. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum.Arch Intern Med 1992; 152: 51.

    Google Scholar 

  19. Palestro CJ, Kim CK, Swyer AJ, Vallabhajosula S, Goldsmith SJ. Radionuclide diagnosis of vertebral osteomyelitis: indiumI11-leukocyte and Tc-99m methylene diphosphonate bone scintigraphy.J Nucl Med 1991; 32: 1861–1865.

    Google Scholar 

  20. Reuland P, Winker KH, Heuchert T, Ruck P, Müller-Schauen-burg W, Weller S, Feine U. Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes.J Nucl Med 1991; 32: 526–531.

    Google Scholar 

  21. Hotze A, Briele B, Overbeck B, Knepp J, Grünwald F, Mekkawy MA, von Smekal A, Moeller F, Biersack HJ. Tc-99m-labelled anti-granulocyte antibodies in suspected bone infections.J Nucl Med 1992; 33: 526–531.

    Google Scholar 

  22. Sciuk J, Brandau W, Vollet B, Stücker R, Erlemann R, Barrenstein R, Peters PE, Schober O. Comparison of Tc-99m polyclonal human immunoglobulin and Tc-99m-labeled monoclonal antibodies for imaging chronic osteomyelitis.Eur J Nucl Med 1991; 18: 401–407.

    Google Scholar 

  23. Palestro CJ. The current role of gallium imaging in infection.Semin Nucl Med 1994; XXIV: 128–141.

    Google Scholar 

  24. Hotze A, Mahlstedt J, Wolf F. Knochenmarksszintigraphie: Methode - Indikationen - Ergebnisse. GIT Verlag Ernst Giebler, 1984.

  25. De Schrijver M, Streule K, Senekowitsch R, Fridrich R. Scintigraphy of inflammation with nanometer-sized colloidal tracers.Nucl Med Commun 1987; 8: 895–908.

    Google Scholar 

  26. McAfee JG, Gagne G, Subramanian G, Schneider RF, The localization of indium-111-leukocytes, gallium-67, polyclonal IgG and other radioactive agents in acute focal inflammatory lesions.J Nucl Med 1991; 32: 2126–2131.

    Google Scholar 

  27. Wheeler JG, Slack NF, Duncan A, Palmer H, Harvey RF, Tc99m-nanocolloid in inflammatory bowel disease.Nucl Med Commun 1990; 11: 127–133.

    Google Scholar 

  28. Streule K, de Schrijver M, Friedrich R. Tc-99m-labelled HSA-nanocolloid versus In-111 oxine labeled granulocytes in detecting skeletal septic process.Nucl Med Commun 1988; 9: 59–67.

    Google Scholar 

  29. van Dalen H, Stemfort AF, de Jonge-Bok JM, de Schrijver M. Three phase scintigraphy of Tc-99m nanocoll versus Tc-99m 'MDP in orthopedics. In: Stuttgart: Schattauer; 1989: 474–477

    Google Scholar 

  30. Vorne M, Lantto S, Paakkinen S, Salo S, Soini I. Clinical comparison of Tc-99m HMPAO labeled leukocytes and Tc99m-nanocolloid in the detection of inflammation.Acta Radiol 1989; 30: 633–637.

    Google Scholar 

  31. Hotze A, Bokisch A, Rüther M, Biersack HJ. Comparison of Tc-99m-HMPAO labelled leukocytes and Tc-99m nanocolloid in osteomyelitis.Nukl Med 1988; 27: 63–65.

    Google Scholar 

  32. Flivik G, Sloth M, Rydholm U, Herrlin K, Lidgren L. Technetium-99m-nanocolloid scintigraphy in orthopedic infections: a comparison with In-111-labeled leukocytes.J Nucl Med 1993; 34:1646–1650.

    Google Scholar 

  33. Liberatore M, Clemente M, Iurilli AP, Zorzin L, Masini M, Di Rocco E, Centi Colella A. Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloids.Eur J Nucl Med 1992; 19: 853–857.

    Google Scholar 

  34. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. I. Soluble agents.J Nucl Med 1976; 17: 480–487.

    Google Scholar 

  35. McAfee JG, Thakur ML. Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. II. Particles.J Nucl Med 1976; 17: 488–492.

    Google Scholar 

  36. Spector WG, Lykke WJ, Willoubhgy PA. A quantitative study of leukocyte emigration in chronic inflammatory granulomata.J Pathol Bacteriol 1967; 93: 101–107.

    Google Scholar 

  37. McAfee JG, Gagne GM. Subramanian G. Distribution of leukocytes labeled with In- 111-oxine in dogs with acute inflammatory lesions.J Nucl Med 1980; 21: 1059–1068.

    Google Scholar 

  38. Thakur ML, Lavender JP, Arnot RN, Silvester DJ, Segal AW. Indium-111-labeled autologous leukocytes in man.J Nucl Med 1977; 18: 1012–1021.

    Google Scholar 

  39. Becker W, Fischbach W, Refiners C, Börner W. Three-phase white blood cell scan: diagnostic validity in abdominal inflammatory diseases.J Nucl Med 1986; 27: 1109–1115.

    Google Scholar 

  40. Saverymuttu SH, Peters AM, Chadwick VJ, Hodgson HJ, Lavender JP. Imaging diseased bowel with In-111 labelled white cells.Br J Radiol 1981; 54: 707.

    Google Scholar 

  41. Peters AM, Saverymuttu SH, Keshavarzian A, Bell RN, Lavender JP. Imaging of inflammation with In-111-tropolonate labeled leukocytes.J Nucl Med 1983; 24: 39–44.

    Google Scholar 

  42. Sinn H, Silvester DJ. Simplified cell labelling with In-111 acetylacetone.Br J Radiol 1979; 52: 758–759.

    Google Scholar 

  43. Datz FL. In-111-labeled leukocytes for the detection of infection: current status.Semin Nucl Med 1994; XXIV: 92–109.

    Google Scholar 

  44. Golden DW, Cline MJ. Production, distribution and fate of granulocytes. In: Williams WJ, Beutler E, Erslev AJ, et al., eds.Hematology, 2nd edn. New York: McGraw Hill, 1977: 699–706.

    Google Scholar 

  45. Athens JW, Haab OP, Raab SO. Leukokinetic studies: the total blood, circulating and marginal granulocyte pools and granulocyte turnover rate in normal subjects.J Clin Invest 1961; 40: 989–995.

    Google Scholar 

  46. Weiblen BJ, Forstrom LA, McCullough J. Kinetics of In-111-labelled granulocytes.J Lab Clin Med 1979; 94: 246–255.

    Google Scholar 

  47. Bassano DA, McAfee JG. Cellular radiation doses of labeled neutrophils and platelets.J Nucl Med 1979; 20: 255–259.

    Google Scholar 

  48. Thakur ML, McAfee JG. The significance of chromosomal aberrations in In-111-lymphocytes.J Nucl Med 1984; 25: 922–927.

    Google Scholar 

  49. swald SG, Norstrand DV, Savory CG, et al. Three phase bone scan and indium white blood cell scintigraphy following porous coated hip arthroplasty: a prospective study of the prosthetic hip.J Nucl Med 1989; 30: 1321–1331.

    Google Scholar 

  50. Saverymuttu SH, Camillieri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS. Indium-111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology and fecal indium-111-granulocyte excretion.Gastroertterology 1986; 90: 1121–1128.

    Google Scholar 

  51. Becker W, Fischbach W, Jenett M, Reiners C, Börner W. In-111-oxine labelled white cells in the diagnosis and follow-up of Crohn's disease.Klin Wochenschr 1986; 64: 141–148.

    Google Scholar 

  52. Fischbach W, Becker W. Clinical relevance of activity parameters in Crohn's disease estimated by fecal excretion of In-11l-labeled granulocytes.Digestion 1991; 50: 149–152.

    Google Scholar 

  53. Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabeled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications.Nucl Med Commun 1988; 9: 693–701.

    Google Scholar 

  54. Saverymuttu SH, Crofton ME, Peters AM, Lavender JP. Indium-111 tropolonate leukocyte scanning in the detection of intra-abdominal abscesses.Clin Radiol 1983; 34: 593–596.

    Google Scholar 

  55. McCarthy K, Velchik MG, Alavi A, Mandell GA, Esterhai JL, Goll S. In-111-Labelled white blood cells in the detection of osteomyelitis complicated by a pre-existing condition.J Nucl Med 1988; 29: 1015–1021.

    Google Scholar 

  56. Pring DJ, Henderson RG, Keshavarzian A, Riven AG, Krausz T, Coombs RRH, Lavender JP. Indium granulocyte scanning in painful prosthetic joint.Radiology 1991; 179: 645–647.

    Google Scholar 

  57. Palestro CJ, Kim DK, Swyer AJ, Vallabhajosula S, Goldsmith S. Radionuclide diagnosis of vertebral osteomyelitis: In-111leukocyte and Tc-99m methylene diphosphonate bone scintigraphy.J Nucl Med 1991; 32: 1861–1865.

    Google Scholar 

  58. Van Royen EA, Rövekamp MH, van Dongen RJAM, van de Schoot JB, Hardeman RM. In-111-leukocyte scintigraphy in the diagnosis of vascular graft infection. In: Hardeman MR, Najean Y eds. Blood cells in nuclear medicine. Part I. cell kinetics and biodistribution. The Hague: Martinus Nijhoff; 1984: 341–347.

    Google Scholar 

  59. Becker W, Düsel W, Berger P, Spiegel W. The In-1 11-granulocyte scan in prosthetic vascular graft infections: imaging technique and results. Eur J Nucl Med 1987; 13: 225–229.

    Google Scholar 

  60. Becker W, Borst U, Maisch B, Epping J, Börner W, Kochsiek K. In-111-labelled granulocytes in inflammatory heart diseases.Eur Heart J 1987; 8 Suppl J: 307–310.

    Google Scholar 

  61. Borst U, Becker W, Maisch B, Börner W, Kochsiek K. Clinical and prognostic effect of a positive granulocyte scan ineffective endocarditis. Clin Nucl Med 1993; 18: 35–39.

    Google Scholar 

  62. Becker W, Götz R, Heidbreder W, Börner W. Indium-11 white blood cell scan in the diagnosis of infectious complications in patients undergoing regular dialysis treatment. In: Bischof-Elaloye A, Blaufox MD, eds.Radionuclides in nephrology. Basel: Karger; 1986: 191–195.

    Google Scholar 

  63. Cook PS, Datz FL, Disbro MA, Alazraki NP, Taylor AT. Pulmonary uptake in In-111-leukocyte imaging: clinical significance in patients with suspected occult infection.Radiology 1984; 150: 557–561.

    Google Scholar 

  64. Saverymuttu SH, Phillips G, Peters AM, Lavender JP. Indium-111 autologous leukocyte scanning in lobar pneumonia and lung abscesses.Thorax 1985; 40: 925–930.

    Google Scholar 

  65. MacSweeney JE, Peters AM, Lavender JP. Indium labelled leukocyte scanning in pyrexia of unknown origin.Clin Radiol 1990; 42: 414–417.

    Google Scholar 

  66. Hawker RJ, Hall CE, Drole Z, Rhys-Evans PH. Indium leukocyte imaging in true pyrexia of unknown origin.Eur J Nucl Med 1985; 10: 172–174.

    Google Scholar 

  67. Becker W, Schomann E, Fischbach W, Börner W, Gruner KR. Comparison of Tc-99m-HMPAO and In-111-oxine labelled granulocytes in man: first clinical results.Nucl Med Commun 435-447;9:1988.

    Google Scholar 

  68. Saverymuttu SH, Peters AM, Lavender JP. Clinical importance of enteric communications with abdominal abscesses.Br Med J 1985; 290: 23–27.

    Google Scholar 

  69. Arndt JW, Van der Sluys Veer A, Blok D, Niffioen G, Verspager HW, Lamers CBHW, Pauwels EKJ. Prospective comparative study of Tc-99m-WBCs and indium-111 granulocytes for the examination of inflammatory bowel disease.J Nucl Med 1991; 32: 2029–2034.

    Google Scholar 

  70. Allan RA, Sladen GE, Bassingham S, Lazarus C, Clarke SEM, Fogelman I. Comparison of simultaneous Tc-99mHMPAO and In-111-oxine labelled white blood cell scans in the assessment of inflammatory bowel disease.Eur J Nucl Med 1993; 20: 195–200.

    Google Scholar 

  71. eters AM. The utiliy of Tc-99m-HMPAO leukocytes for imaging infection.Semin Nucl Med 1994; XXIV: 110–127.

    Google Scholar 

  72. Currie DC, Saverymuttu SH, Peters AM, Needham SG, George P, Dhillon DP, Lavender JP, Cole PJ. In-111-labelled granulocyte accumulation in respiratory tract of patients with bronchiectasis.Lancet 1987; I: 1335–1339.

    Google Scholar 

  73. Currie DC, Peters AM, Garbett ND, George P, Strickland B, Lavener JP, Cole PJ. In-111-labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectoration.Thorax 1990; 45: 541–544.

    Google Scholar 

  74. Jonker N, Peters AM, Carpani de Kaski M, Hodgson HJ, Lavender JP. A retrospective study of granulocytic kinetics in patients with systemic vasculitis.J Nucl Med 1992; 33: 491–497.

    Google Scholar 

  75. Locher IT, Seybold K, Andres RY, Schubiger PA, Mach JP, Buchegger F. Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal antigranulocyte antibodies.Nucl Med Commun 1986; 7: 659–670.

    Google Scholar 

  76. Joseph K, Höffken H, Damann V. In-vivo-Markierung von Granulozyten mit Tc-99m-markierten monoklonalen Antik6rpern: erste klinische Ergebnisse.NucCompact 1987; 18: 223–226.

    Google Scholar 

  77. Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H, Gramatzki M, Winship MJ, Goldenberg DM, Wolf F. Detection of soft-tissue infections and osteomyelitis using a rechnetium-99m-labeled antigranulocyte monoclonal antibody fragment.J Nucl Med 1994; 35: 1436–1443.

    Google Scholar 

  78. Becker W, Goldenberg DM, Wolf F. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions.Semin Nucl Med 1994; XXIV: 1–13.

    Google Scholar 

  79. Becker W, Fleig W, Marienhagen J, Hahn E, Wolf F. Diagnostische Bedeutung der intestinalen Aktivitat bei der Immunszintigraphie mit Tc-99m-NCA-95-Antikörperu.Nukl-Med 1990; 229: 47–48.

    Google Scholar 

  80. Segarra I, Roca M, Baliellas C, Vilar L, Ricart Y, Mora J, Puchal R, Martin-Comin J. Granulocyte-specific monoclonal antibody technetium-99m BW 250/183 and In-111-oxine labelled leukocyte scintigraphy in inflammatory bowel disease.Eur J Nucl Med 1991; 18: 715–719.

    Google Scholar 

  81. Cordes M, Hepp W, Langer R, Pannhorst J, Hierholzer J, Felix R. Vascular graft infection: detection by I-123-labeled antigranulocyte antibody (anti-NCA-95) scintigraphy.Nucl Med 1991; 30: 173–177.

    Google Scholar 

  82. Munz DL, Morguet AJ, Sandrock D, Heim A, Sold G, Figulla HR, Kreuzer H, Emrich D. Radioimmunoimaging of subacute infective endocarditis using a technetium-99m monoclonal granulocyte specific antibody.Eur J Nucl Med 1991; 18: 977–980.

    Google Scholar 

  83. Lind P, Langsteger W, Költringer P, Dimai HP, Passl R, Eber O. Immunoscintigraphy of inflammatory processes with a technetium-99m-labelled monoclonal antigranulocyte antibody (Mab BW 250/183).J Nucl Med 1990; 31: 417–423.

    Google Scholar 

  84. Prvulovich EM, Miller RF, Costa DC, Severn A, Corbett E, Bomanij J, Becker WS, Ell PJ. Immunoscintigraphy with a Tc-99m-labelled antigranulocyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS. AIDS 1995 (submitted).

  85. Rubin RH, Young LS, Hansen P, Nedelman M, Wilkinson R, Nelles MJ, Callahan R, Khaw BA, Strauss HW. Specific and nonspecific imaging of localized Fisher immunotype. 1. Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody.J Nucl Med 1988; 29: 651–656.

    Google Scholar 

  86. Corstens FHM, Oyen WJG, Becker WS. Radioimmunoconjugates in the detection of infection and inflammation.Semin Nucl Med 148–164; XXIII: 1993.

    Google Scholar 

  87. Corstens FHM, Claessens RAMJ. Imaging inflammation with human polyclonal immunoglobulin: not looked for, but discovered.Eur J Nucl Med 1992; 19: 155–158.

    Google Scholar 

  88. Claessens RAMJ, Koenders EB, Boerman OC, Oyen WJG, Borm GF, Van der Meer JWM, Corstens FHM. Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.Eur J Nucl Med 1995; 22: 212–219.

    Google Scholar 

  89. Juweid M, Strauss HW, Yaoita H, Rubin RH, Fischman AJ. Accumulation of immunoglobulin G at focal sites of inflammation.Eur J Nucl Med 1992; 19: 159–165.

    Google Scholar 

  90. Serafmi AN, Garty I, Vargas-Cuba R, Friedman A, Rauh DA, Neptune M, Laundres L, Sfakianakis GN. Clinical evaluation of a scintigraphic method for diagnosing inflammation/infections using indium-111 labeled nonspecific human IgG.J Nucl Med 1991; 32: 2227–2232.

    Google Scholar 

  91. Rubin RH, Fischman AJ, Callahan RJ, Khaw BA, Keech F, Ahmed M, Wilkinson R, Strauss HW. In-111 labeled nonspecific immunoglobulin scanning in the detection of focal infection.N Engl J Med 1989; 321: 935–940.

    Google Scholar 

  92. Buscombe JR, Oyen WJG, Miller RF, Grant A, Claessens RAMJ, Van der Meer J, Corstens FHM, Ell JP, Miller RF. Indium-111 labeled human polyclonal immunoglobulin identifying focal infection in patients positive for human immunodeficiency virus (HIV).J Nucl Med 1993; 34: 1621–1625.

    Google Scholar 

  93. Oyen WJG, van Horn JR, Claessens RAMJ, Slooff TJJH, Van der Meer WMJ, Corstems FMH. Diagnosis of bone, joint and joint prosthesis infections with indium-111 labelled human im munoglobulin G scintigraphy.Radiology 1992; 182: 195–199.

    Google Scholar 

  94. Oyen WJG, van Horn JR, Claessens RAMJ, Slooff TJJH, Van der Meer JWM, Corstens FHM. Diagnosing prosthetic joint infections.J Nucl Med 1991; 32: 2195–2196.

    Google Scholar 

  95. De Kleijn EMHA, Oyen WIG, Claessens RAMJ, Corstens FMH, Van der Meer JWM. Scintigraphy with In-111 labeled polyclonal human immunoglobulin G (In-111-IgG) on patients with fever of unknown origin (FUO).Nucl Med Commun 1992; 13: 626.

    Google Scholar 

  96. Calame W, Feitsma HIJ, Ensing GJ, Arndt JW, van Furth R, Pauwels EKJ. Binding of Tc-99m-labelled polyclonal immunoglobulin to bacteria as a mechanism for scintigraphic detection of infection.Eur J Nucl Med 1991; 18: 396–400.

    Google Scholar 

  97. Oyen WJG, Claessens RAMJ, van der Meer JMW, Corstens FMH. Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.J Nucl Med 1992; 33: 651–656.

    Google Scholar 

  98. Saptogino A, Becker W, Wolf F. Biokinetics and estimation of dose from Tc-99m-labelled polyclonal human immunoglobulin (HIG).Nucl Med 1991; 30: 18–23.

    Google Scholar 

  99. Buscombe JR, Miller RF, Lui D, Ell PJ. Combined Ga-67-citrate and Tc-99m human immunoglobulin imaging in human immunodeficiency virus-positive patients with fever of unknown origin.Nucl Med Commun 1991; 12: 583–592.

    Google Scholar 

  100. Spinelli F, Milella M, Sara R, Banfi F, Possa M, Vigorelli R. The value of Tc-99m-labelled human immunoglobulin scanning in the evaluation of Crohn's disease [abstract].Eur J Nucl Med 1990; 16: 436.

    Google Scholar 

  101. Sciuk J, Braundau W, Vollet B, Stücker R, Erlemann R, Bartenstein P, Peters PE, Schober O. Comparison of technetium99m polyclonal human immunoglobulin and technetium-99m monoclonal antibodies for imaging chronic osteomyelitis.Eur J Nucl Med 1991; 18: 401–407.

    Google Scholar 

  102. Breedveld FC, Kroonenburgh MJPG, Camps JAJ, Feitsma HIJ, Markusse HM, Pauwels EKJ. Imaging of inflammatory arthritis with technetium-99m-labelled IgG.J Nucl Med 1989; 30: 2017–2021.

    Google Scholar 

  103. Berna L, Torres G, Diez C, Estorch M, Martinez-Duncker D, Carrio I. Technetium-99m human polyclonal immunoglobulin G studies and conventional bone scans to detect active joint inflammation in chronic rheumatoid arthritis.Eur J Nucl Med 1992; 19: 173–176.

    Google Scholar 

  104. De Bois MHW, Arndt JW, Tak PP, Kluin PM, Van der Velde EA, Pauwels EKJ, Breedveld FC. Tc-99m-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis.Nucl Med Commun 1993; 14: 883–887.

    Google Scholar 

  105. De Bois MHW, Arndt JW, Van der Velde EA, Pauwels EKJ, Breedveld FC. Joint scintigraphy for quantification of synovitis with Tc-99m-labelled human immunoglobulin G com pared to late phase scintigraphy with Tc-99m labelled diphosphonate.Br J Rheumatol 1994; 33: 67–73.

    Google Scholar 

  106. De Bois MHW, Arndt JAW, Van der Velde EA, Van der Lubbe PAHM, Westedt ML, Pauwels EKJ, Breedveld FC, Tc-99m human immunoglobulin scintigraphy — a reliable method to detect joint activity in rheumatoid arthritis. J Rheumatol 1992; 19: 1371–1376.

    Google Scholar 

  107. Becker W, Bair J, Behr T, Repp R, Streckenbach H, Beck H, Gramatzki M, Winship MJ, Goldenberg DM, Wolf E, Detection of soft-tissue infections and osteomyelitis using a tech netium-99m labeled antigranulocyte monoclonal antibody fragment.J Nucl Med 1994; 35: 1436–1443.

    Google Scholar 

  108. Signore A, Parman A, Pozilli P, Andreani D, Beverley PCL. Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 1-123-interleukin-2: an early sign of type 1 diabetes.Lancet 1987; II: 537–541.

    Google Scholar 

  109. Signore A, Chianelli M, Ferretti E, Toscano AM, Britton KE, Andreani D, Gale EAM, Pozilli P. A new approach for in vivo detection of insulinitis: activated lymphocyte targeting with I-123-labelled interleukin-2.Eur J Endocrinol 1994; 131: 431–437.

    Google Scholar 

  110. Van der Laken J, Boerman OC, Oyen WIG, Van de Ven MTP, Makarewicz J, Caessens RAMJ, Van der Meer JWM, Corstens FMH. Recombinant human interleukin-1: potential agent to image infectious foci.Eur J Nucl Med 1994; 21: 790.

    Google Scholar 

  111. Keelan ETM, Harrison AA, Chapman PT, Binns RM, Peters AM, Haskard DO. Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin.J Nucl Med 1994; 35: 276–281.

    Google Scholar 

  112. chiffmann E, Corcoran BA, Wahl SM. Formlymethionyl peptides as chemoattractants for leukocytes.Proc Natl Acad Sci USA 1972; 72: 1059–1062.

    Google Scholar 

  113. Becker EJ. The formylpeptide receptor of the neutrophil: a search and conserve operation.Am J Pathol 1987; 129: 16–24.

    Google Scholar 

  114. Fischman AJ, Babich JW, Rubin RH. Infection imaging with technetium-99m-labeled chemotactic peptide analogs.Semin Nucl Med 1994; XXIV: 154–168.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University of Göttingen, Robert-Koch-Str. 40, D-37075, Göttingen, Germany

    W. Becker

Authors
  1. W. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper is dedicated to Professor Dr. Friedrich Wolf, Head of the Department of Nuclear Medicine of the University of Erlangen-Nuremberg, on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Becker, W. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med 22, 1195–1211 (1995). https://doi.org/10.1007/BF00800606

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00800606

Key words

Search

Navigation